Alphanox Co.,Ltd. (KOSDAQ:043100)

Market Cap	71.56B
Revenue (ttm)	26.59B
Net Income (ttm)	-7.66B
Shares Out	17.10M
EPS (ttm)	-744.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,733
Average Volume	224,571
Open	3,845.00
Previous Close	3,845.00
Day's Range	3,800.00 - 4,040.00
52-Week Range	1,160.00 - 5,030.00
Beta	0.46
RSI	68.82
Earnings Date	Aug 14, 2025

About Alphanox

Alphanox Co.,Ltd. manufactures and sells medical devices and healthcare products in South Korea. The company offers surgical instruments, trays and containers, and disposable and custom-made devices; spine, trauma, and joint implants; and in vitro diagnostic devices. It also provides direct, dispenser, and portable type hydrogen water generators; medical devices, such as personal and functional devices, dietary supplements, beauty care products, and pillows. The company was formerly known as Solco Biomedical Co., Ltd. and changed its name to Al...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1974
• Employees: 102
• Stock Exchange: KOSDAQ
• Ticker Symbol: 043100

Financial Performance

In 2024, Alphanox's revenue was 26.81 billion, a decrease of -0.26% compared to the previous year's 26.88 billion. Losses were -7.08 billion, -64.89% less than in 2023.